Serological Immune Response Against ADAM10 Pro-Domain Is Associated With Favourable Prognosis in Stage III Colorectal Cancer Patients

Oncotarget - United States
doi 10.18632/oncotarget.11181
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

MAPT Promoter CpG Island Hypermethylation Is Associated With Poor Prognosis in Patients With Stage II Colorectal Cancer

Cancer Management and Research
Oncology
2019English

Methylation of MGMT Is Associated With Poor Prognosis in Patients With Stage III Duodenal Adenocarcinoma

PLoS ONE
Multidisciplinary
2016English

The Significance of Tumor-Associated Immune Response in Molecular Taxonomy, Prognosis and Therapy of Colorectal Cancer Patients

Annals of Translational Medicine
Medicine
2016English

Upregulation of microRNA‑31 Is Associated With Poor Prognosis in Patients With Advanced Colorectal Cancer

Oncology Letters
Cancer ResearchOncology
2020English

Immune Response in Patients With Colorectal Cancer in Postoperative Period

Grekov's Bulletin of Surgery
2015English

P53 Expression Status Is Associated With Cancer-Specific Survival in Stage III and High-Risk Stage II Colorectal Cancer Patients Treated With Oxaliplatin-Based Adjuvant Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
2019English

Low Expression of LOC285194 Is Associated With Poor Prognosis in Colorectal Cancer

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2013English

Serological Markers Associated With Response to Immune Checkpoint Blockade in Metastatic Gastrointestinal Tract Cancer

JAMA network open
Medicine
2019English

Preoperative Prognostic Nutritional Index Is a Powerful Predictor of Prognosis in Patients With Stage III Ovarian Cancer

Scientific Reports
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy